US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VEGASHARES TRILLIONS ETF

25.55

+0.43891.75%

Volume:2K

Turnover:52.63K

Market Cap:1.28M

PE:- -

High:25.65

Open:25.54

Low:25.52

Close:25.11

52wk High:25.65

52wk Low:24.93

Shares:50.00K

Float Shares:50.00K

Volume Ratio:0.37

T/O Rate:4.12%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

VEGASHARES TRILLIONS ETF

Exchange:

CBOE

Establishment Date:

- -

Employees:

- -

Office Location:

234 West Florida Street,Suite 700,Milwaukee,Wisconsin,United States

Website:

http://www.trilliumtherapeutics.com

Zip Code:

53204

Phone:

Fax:

- -

Introduction:

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/TRIL/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TRIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRIL\",,,,,undefined,":{"symbol":"TRIL","market":"US","secType":"STK","nameCN":"VEGASHARES TRILLIONS ETF","latestPrice":25.5516,"timestamp":1790971200000,"preClose":25.1127,"halted":0,"volume":2058,"delay":0,"changeRate":0.01747721272503555,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Market Closed","change":0.4389,"latestTime":"10-02 16:00:00 EDT","open":25.54,"high":25.65,"low":25.52,"amount":52629,"amplitude":0.005177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1790827200000,"exchange":"CBOE","adjPreClose":25.1127,"sharesOutstanding":50000,"nav":19.86,"aum":501400,"bidAskSpread":0,"volumeRatio":0.36704120046571004,"impliedVol":0.3281,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRIL\",,,,,undefined,":{"symbol":"TRIL","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.36704120046571004,"shares":50000,"dividePrice":0,"high":25.65,"amplitude":0.005177,"preClose":25.1127,"low":25.52,"week52Low":24.93,"pbRate":"--","week52High":25.65,"institutionHeld":0,"latestPrice":25.5516,"eps":0,"divideRate":0,"volume":2058,"delay":0,"ttmEps":0,"open":25.54,"prevYearClose":25.01,"prevWeekClose":25.01,"prevMonthClose":25.01,"prevQuarterClose":25.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRIL\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRIL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRIL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRIL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRIL","date":"2021-11-09","current":-47.117447,"percent":1,"low":-47.88741,"twenty":-47.596535,"median":-47.459653,"eighty":-47.339881,"high":-47.117447,"avg":-47.470347,"sd":0.192193,"marketCap":2313042603},"quantilePoints":[{"date":"2021-10-29","current":-47.331326,"twenty":-47.489596,"median":-47.459653,"eighty":-47.365547,"marketCap":2323542116},{"date":"2021-11-05","current":-47.523817,"twenty":-47.558037,"median":-47.459653,"eighty":-47.365547,"marketCap":2332991677},{"date":"2021-11-09","current":-47.117447,"twenty":-47.596535,"median":-47.459653,"eighty":-47.339881,"marketCap":2313042603}],"updateTime":1791091571408},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2007260347,"address":"234 West Florida Street,Suite 700,Milwaukee,Wisconsin,United States","zipCode":"53204","officePhone":"855-843-2534"},"stockCompanyDetail":{"websiteUrl":"http://www.trilliumtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0217},{"period":"ytd","weight":0.0217}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts.","exchange":"CBOE","name":"VEGASHARES TRILLIONS ETF","nameEN":"VEGASHARES TRILLIONS ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TRIL\",market:\"US\",,,undefined,":null}}